Activation of the somatic PI3K pathway (which includes PTEN) has been shown to contribute to radiotherapy resistance in various cancer types [13, 14], and PTEN activity in stromal breast tissue has been associated with diminished radiotherapy and chemotherapy responses [15, 16]. The gene discussed is PTEN; the disease is cancer.